Public
- Public
- Network
- Groups
- Featured
- Popular
- People

Conversation

Notices

Embed this notice
Brian Vastag (brianvastag@sciencemastodon.com)'s status on Wednesday, 04-Sep-2024 03:45:09 JST Brian Vastag

Pharma company BioVie announces phase 2 trial of investigational new drug for #LongCovid. The drug candidate, bezesterim, is also being tested in patients with Alzheimer's & Parkinson's diseases. The company says it crosses the blood-brain barrier & reduces neuroinflammation, which is often seen in long covid.
It's being funded by DOD.
https://finance.yahoo.com/news/biovie-announces-fda-authorization-investigational-120000163.html
In conversation about 3 months ago from sciencemastodon.com permalink
Attachments
1. Domain not in remote thumbnail source whitelist: media.zenfs.com
  
  BioVie Announces FDA Authorization of Investigational New Drug Application for Phase 2 Trial to Evaluate Bezisterim in Long COVID
  
  Authorization expands use of bezisterim in a Phase 2, placebo-controlled, multicenter trial assessing bezisterim’s impact on neurological symptoms associated with long COVID Key milestone reached ahead of schedule, with BioVie on track to receive additional $12.6 million of award from the U.S. Department of Defense and initiate the Phase 2 trial Recent Centers for Disease Control and Prevention survey estimated over 5% of U.S. adults currently have long COVID, and ~3.6 million people reported si

Feeds